Try the modernized beta website. Learn more about the modernization effort.
Working… Menu

A Study of Pembrolizumab in Patients With Advanced Gynaecological Clear Cell Cancer (PEACOCC)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT03425565
Recruitment Status : Active, not recruiting
First Posted : February 7, 2018
Last Update Posted : October 25, 2021
Information provided by (Responsible Party):
University College, London

No Study Results Posted on for this Study
Recruitment Status : Active, not recruiting
Estimated Primary Completion Date : September 2024
Estimated Study Completion Date : September 2024